These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2749889)

  • 1. The effects of polyinosinic:polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment.
    Peres A; Amlani S; Kornbluth M; Seemayer TA; Lapp WS
    Transplantation; 1989 Jul; 48(1):80-4. PubMed ID: 2749889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of polyinosinic: polycytidylic acid (pI:C) on the GVH reaction: immunopathological observations.
    Peres A; Seemayer TA; Lapp WS
    Clin Immunol Immunopathol; 1986 Apr; 39(1):102-11. PubMed ID: 3948433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action.
    Shand FL
    Immunology; 1976 Dec; 31(6):943-51. PubMed ID: 11181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
    Holda JH; Maier T; Claman HN
    J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Shand FL
    Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions.
    Gibbons JJ; Lucas J
    J Immunol; 1989 Mar; 142(6):1867-73. PubMed ID: 2784139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U; Shearer GM
    J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of concanavalin A. IV. The effect of Con A on the local graft versus host (GvH) reaction in the mouse popliteal lymph node.
    Mioduszewska O; Mościcka-Wesołowska M; Skopińska-Rózewska E; Wasik M
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):385-90. PubMed ID: 7294974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-vs-host reactions in F1 mice induced by parental lymphoid cells: nature of recruited F1 cells.
    Romano TJ; Ponzio NM; Thorbecke GJ
    J Immunol; 1976 Jun; 116(6):1618-23. PubMed ID: 5562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.
    Ghayur T; Seemayer TA; Xenocostas A; Lapp WS
    Am J Pathol; 1988 Oct; 133(1):39-46. PubMed ID: 3263049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of graft-vs-host induced immunodeficiency with immunosuppressive therapy.
    Smith SR; Pennline K; Terminelli C; DaFonseca M; Pellerito F; Umland S
    Immunopharmacol Immunotoxicol; 1988; 10(4):545-78. PubMed ID: 2977607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.